Cargando…
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19
The human immune system protects the body against invasive organisms and kicks into a hyperactive mode in COVID-19 patients, particularly in those who are critically sick. Therapeutic regimens directed at the hyperactive immune system have been found to be effective in the treatment of patients with...
Autores principales: | Manoharan, Ragul, Kore, Rajshekhar A, Mehta, Jawahar L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298490/ https://www.ncbi.nlm.nih.gov/pubmed/35855633 http://dx.doi.org/10.2217/imt-2021-0245 |
Ejemplares similares
-
NLRP3 inflammasome via IL-1β regulates PCSK9 secretion
por: Ding, Zufeng, et al.
Publicado: (2020) -
Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes
por: Kore, Rajshekhar A., et al.
Publicado: (2019) -
NLRP3 inflammasome via IL-1β regulates PCSK9 secretion: Erratum
por: Ding, Zufeng, et al.
Publicado: (2022) -
Author Correction: Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes
por: Kore, Rajshekhar A., et al.
Publicado: (2022) -
Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes
por: Kore, Rajshekhar A., et al.
Publicado: (2023)